Stock Track | Day One Biopharma Soars After Smashing Q3 Earnings Estimates

Stock Track

2024/10/31

Shares of Day One Biopharmaceuticals Inc. (DAWN) skyrocketed over 7% in after-hours trading on Tuesday, following the company's impressive third-quarter earnings report that far exceeded Wall Street's expectations.

The biopharmaceutical company reported quarterly earnings of $0.38 per share, compared to analysts' consensus estimate of a loss of $0.39 per share. Day One's quarterly revenue of $93.761 million also crushed estimates of $23.545 million, marking a nearly 300% upside surprise.

The stellar financial results underscore Day One's progress in developing innovative cancer therapies and advancing its robust pipeline. Investors cheered the company's strong performance, driving the stock to surge in extended trading hours.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1133249134"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1133249134\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1133249134?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-31 04:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133249134","market":"us","top_or_hot":-1,"title":"Stock Track | Day One Biopharma Soars After Smashing Q3 Earnings Estimates","media":"Stock Track","content":"<p>Shares of Day One Biopharmaceuticals Inc. (DAWN) skyrocketed over 7% in after-hours trading on Tuesday, following the company's impressive third-quarter earnings report that far exceeded Wall Street's expectations.</p>\n\n<p>The biopharmaceutical company reported quarterly earnings of $0.38 per share, compared to analysts' consensus estimate of a loss of $0.39 per share. Day One's quarterly revenue of $93.761 million also crushed estimates of $23.545 million, marking a nearly 300% upside surprise.</p>\n\n<p>The stellar financial results underscore Day One's progress in developing innovative cancer therapies and advancing its robust pipeline. Investors cheered the company's strong performance, driving the stock to surge in extended trading hours.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Day One Biopharma Soars After Smashing Q3 Earnings Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Day One Biopharma Soars After Smashing Q3 Earnings Estimates\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2024-10-31 04:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shares of Day One Biopharmaceuticals Inc. (DAWN) skyrocketed over 7% in after-hours trading on Tuesday, following the company's impressive third-quarter earnings report that far exceeded Wall Street's expectations.</p>\n\n<p>The biopharmaceutical company reported quarterly earnings of $0.38 per share, compared to analysts' consensus estimate of a loss of $0.39 per share. Day One's quarterly revenue of $93.761 million also crushed estimates of $23.545 million, marking a nearly 300% upside surprise.</p>\n\n<p>The stellar financial results underscore Day One's progress in developing innovative cancer therapies and advancing its robust pipeline. Investors cheered the company's strong performance, driving the stock to surge in extended trading hours.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DAWN","symbol_name":"Day One Biopharmaceuticals Inc.","start_time":0,"source_url":"","article_id":"1133249134","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133249134","pubTimestamp":1730320377,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Day One Biopharmaceuticals Inc.  skyrocketed over 7% in after-hours trading on Tuesday, following the company's impressive third-quarter earnings report that far exceeded Wall Street's expectations.The biopharmaceutical company reported quarterly earnings of $0.38 per share, compared to analysts' consensus estimate of a loss of $0.39 per share. Day One's quarterly revenue of $93.761 million also crushed estimates of $23.545 million, marking a nearly 300% upside surprise.The stellar fin","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DAWN":"Day One Biopharmaceuticals Inc."},"translate_title":"股票追踪第一天生物制药公司在打破第三季度盈利预期后飙升","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DAWN":1},"content_text":"Shares of Day One Biopharmaceuticals Inc. (DAWN) skyrocketed over 7% in after-hours trading on Tuesday, following the company's impressive third-quarter earnings report that far exceeded Wall Street's expectations.\nThe biopharmaceutical company reported quarterly earnings of $0.38 per share, compared to analysts' consensus estimate of a loss of $0.39 per share. Day One's quarterly revenue of $93.761 million also crushed estimates of $23.545 million, marking a nearly 300% upside surprise.\nThe stellar financial results underscore Day One's progress in developing innovative cancer therapies and advancing its robust pipeline. Investors cheered the company's strong performance, driving the stock to surge in extended trading hours.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}